Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002288228 | SCV002578886 | uncertain significance | not provided | 2022-04-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV003097760 | SCV003548635 | uncertain significance | Inborn genetic diseases | 2021-09-27 | criteria provided, single submitter | clinical testing | The c.9910G>A (p.D3304N) alteration is located in exon 29 (coding exon 29) of the PKD1 gene. This alteration results from a G to A substitution at nucleotide position 9910, causing the aspartic acid (D) at amino acid position 3304 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Athena Diagnostics | RCV002288228 | SCV004229853 | uncertain significance | not provided | 2023-03-03 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity (http://gnomad.broadinstitute.org). Computational tools predict that this variant is not damaging. |
Fulgent Genetics, |
RCV005008523 | SCV005638599 | uncertain significance | Polycystic kidney disease, adult type | 2024-05-20 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005008523 | SCV005912200 | uncertain significance | Polycystic kidney disease, adult type | 2021-11-18 | criteria provided, single submitter | clinical testing |